Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-08-17

FDA Approved: GLIPIZIDE AND METFORMIN HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approved a supplemental application for GLIPIZIDE AND METFORMIN HYDROCHLORIDE (Teva), a fixed-dose combination product. The action pertains to supplemental …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Glipizide and Metformin Hydrochloride (glipizide and metformin hydrochloride)

Snippet

SUPPL AP for GLIPIZIDE AND METFORMIN HYDROCHLORIDE (GLIPIZIDE AND METFORMIN HYDROCHLORIDE)